Bayer secures expanded FDA clearances for MRI contrast agent injector
The FDA's expanded clearances broaden the application of Bayer's Medrad MRXperion system across a wider range of MR settings.
05 March 2026
05 March 2026
The FDA's expanded clearances broaden the application of Bayer's Medrad MRXperion system across a wider range of MR settings.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.